Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination.
Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination.
复制标题
DOI:
10.1073/pnas.1721732115
复制
发表时间:
2018-06-12
影响因子:
11.1
通讯作者:
Tiwari-Woodruff SK
中科院分区:
文献类型:
--
作者:
Karim H;Kim SH;Lapato AS;Yasui N;Katzenellenbogen JA;Tiwari-Woodruff SK
CXCL1 is a major neutrophil chemoattractant that binds to the chemokine receptor, CXCR2, on neutrophils and oligodendrocytes. Estrogen receptor β ligand treatment in a mouse model of multiple sclerosis induces an increase in peripheral and brain CXCL1 levels that correlate with an increase in axon remyelination. Oligodendrocyte progenitor recruitment and differentiation by CXCL1, in combination with attenuated IFN-γ production reducing apoptosis, may account for at least one avenue whereby estrogen receptor β ligands exert their clinical benefits. Estrogen receptor β (ERβ) ligands promote remyelination in mouse models of multiple sclerosis. Recent work using experimental autoimmune encephalomyelitis (EAE) has shown that ERβ ligands induce axon remyelination, but impact peripheral inflammation to varying degrees. To identify if ERβ ligands initiate a common immune mechanism in remyelination, central and peripheral immunity and pathology in mice given ERβ ligands at peak EAE were assessed. All ERβ ligands induced differential expression of cytokines and chemokines, but increased levels of CXCL1 in the periphery and in astrocytes. Oligodendrocyte CXCR2 binds CXCL1 and has been implicated in normal myelination. In addition, despite extensive immune cell accumulation in the CNS, all ERβ ligands promoted extensive remyelination in mice at peak EAE. This finding highlights a component of the mechanism by which ERβ ligands mediate remyelination. Hence, interplay between the immune system and central nervous system may be responsible for the remyelinating effects of ERβ ligands. Our findings of potential neuroprotective benefits arising from the presence of CXCL1 could have implications for improved therapies for multiple sclerosis.
登录
查看更多内容
DOI:
10.1111/aji.12021
发表时间:
2013-02
期刊:
American journal of reproductive immunology (New York, N.Y. : 1989)
影响因子:
--
作者:
Hickey DK;Fahey JV;Wira CR
通讯作者:
Wira CR
影响因子:
6.1
作者:
Kumar S;Patel R;Moore S;Crawford DK;Suwanna N;Mangiardi M;Tiwari-Woodruff SK
通讯作者:
Tiwari-Woodruff SK
影响因子:
6.2
作者:
Filipovic, Radmiia;Zecevic, Nada
通讯作者:
Zecevic, Nada
影响因子:
5.3
作者:
Morales, Laurie Beth J.;Loo, Kyi Kyi;Voskuhl, Rhonda R.
通讯作者:
Voskuhl, Rhonda R.
DOI:
10.1073/pnas.1411294111
发表时间:
2014-12-16
影响因子:
11.1
作者:
Moore, Spencer M.;Khalaj, Anna J.;Tiwari-Woodruff, Seema Kaushalya
通讯作者:
Tiwari-Woodruff, Seema Kaushalya